Aardvark Therapeutics Common Stock Price Prediction

AARD Stock   14.16  0.60  4.07%   
The relative strength index (RSI) of Aardvark Therapeutics' stock price is about 63. This suggests that the stock is rather overbought by investors at the present time. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Aardvark, making its price go up or down.

Momentum 63

 Buy Extended

 
Oversold
 
Overbought
The successful prediction of Aardvark Therapeutics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Aardvark Therapeutics and does not consider all of the tangible or intangible factors available from Aardvark Therapeutics' fundamental data. We analyze noise-free headlines and recent hype associated with Aardvark Therapeutics Common, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Aardvark Therapeutics' stock price prediction:
EPS Estimate Current Year
(2.95)
EPS Estimate Next Year
(3.63)
Wall Street Target Price
32.7
Using Aardvark Therapeutics hype-based prediction, you can estimate the value of Aardvark Therapeutics Common from the perspective of Aardvark Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.

Aardvark Therapeutics Hype to Price Pattern

Investor biases related to Aardvark Therapeutics' public news can be used to forecast risks associated with an investment in Aardvark. The trend in average sentiment can be used to explain how an investor holding Aardvark can time the market purely based on public headlines and social activities around Aardvark Therapeutics Common. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Aardvark Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Aardvark Therapeutics.
The fear of missing out, i.e., FOMO, can cause potential investors in Aardvark Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Aardvark because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Aardvark Therapeutics after-hype prediction price

    
  USD 14.86  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Aardvark Therapeutics Basic Forecasting Models to cross-verify your projections.
Intrinsic
Valuation
LowRealHigh
12.7018.4324.16
Details
Naive
Forecast
LowNextHigh
10.3816.1021.83
Details
4 Analysts
Consensus
LowTargetHigh
29.7632.7036.30
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.77-0.74-0.7
Details

Aardvark Therapeutics After-Hype Price Density Analysis

As far as predicting the price of Aardvark Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Aardvark Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Aardvark Therapeutics, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Aardvark Therapeutics Estimiated After-Hype Price Volatility

In the context of predicting Aardvark Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Aardvark Therapeutics' historical news coverage. Aardvark Therapeutics' after-hype downside and upside margins for the prediction period are 9.13 and 20.59, respectively. We have considered Aardvark Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
14.16
14.86
After-hype Price
20.59
Upside
Aardvark Therapeutics is somewhat reliable at this time. Analysis and calculation of next after-hype price of Aardvark Therapeutics is based on 3 months time horizon.

Aardvark Therapeutics Stock Price Outlook Analysis

Have you ever been surprised when a price of a Company such as Aardvark Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Aardvark Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Aardvark Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.57 
5.73
  0.10 
  0.02 
6 Events / Month
5 Events / Month
In about 6 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
14.16
14.86
0.68 
3,183  
Notes

Aardvark Therapeutics Hype Timeline

Aardvark Therapeutics is presently traded for 14.16. The entity has historical hype elasticity of 0.1, and average elasticity to hype of competition of -0.02. Aardvark is projected to increase in value after the next headline, with the price projected to jump to 14.86 or above. The average volatility of media hype impact on the company the price is over 100%. The price growth on the next news is projected to be 0.68%, whereas the daily expected return is presently at 0.57%. The volatility of related hype on Aardvark Therapeutics is about 14325.0%, with the expected price after the next announcement by competition of 14.14. Net Loss for the year was (20.59 M) with profit before overhead, payroll, taxes, and interest of 0. Given the investment horizon of 90 days the next projected press release will be in about 6 days.
Check out Aardvark Therapeutics Basic Forecasting Models to cross-verify your projections.

Aardvark Therapeutics Related Hype Analysis

Having access to credible news sources related to Aardvark Therapeutics' direct competition is more important than ever and may enhance your ability to predict Aardvark Therapeutics' future price movements. Getting to know how Aardvark Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Aardvark Therapeutics may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
ASMBAssembly Biosciences(1.92)7 per month 3.92 (0.02) 5.88 (6.65) 18.53 
ZURAZura Bio Limited(0.02)7 per month 4.03  0.18  9.82 (6.25) 28.57 
NAUTNautilus Biotechnology 0.34 6 per month 5.56  0.09  15.08 (12.00) 53.15 
EPRXEupraxia Pharmaceuticals Common 0.00 0 per month 2.79  0.16  6.98 (4.46) 24.61 
CRBUCaribou Biosciences(0.13)7 per month 0.00 (0.22) 6.86 (8.76) 20.16 
ENTAEnanta Pharmaceuticals 0.22 5 per month 2.69  0.07  5.67 (4.04) 15.79 
TNYATenaya Therapeutics(0.20)5 per month 0.00 (0.17) 9.02 (11.04) 51.79 
AVTXAvalo Therapeutics 1.04 8 per month 0.00 (0.03) 6.93 (6.28) 25.25 
FHTXFoghorn Therapeutics 0.11 9 per month 4.23  0.11  9.16 (5.56) 31.12 
PYXSPyxis Oncology 0.16 8 per month 0.00 (0.07) 17.05 (15.41) 70.66 

Aardvark Therapeutics Additional Predictive Modules

Most predictive techniques to examine Aardvark price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Aardvark using various technical indicators. When you analyze Aardvark charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Aardvark Therapeutics Predictive Indicators

The successful prediction of Aardvark Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Aardvark Therapeutics Common, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Aardvark Therapeutics based on analysis of Aardvark Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Aardvark Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Aardvark Therapeutics's related companies.
 2023 2024 2025 2026 (projected)
ROE0.210.380.430.4
Income Quality0.810.880.790.66

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Complementary Tools for Aardvark Stock analysis

When running Aardvark Therapeutics' price analysis, check to measure Aardvark Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aardvark Therapeutics is operating at the current time. Most of Aardvark Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aardvark Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aardvark Therapeutics' price. Additionally, you may evaluate how the addition of Aardvark Therapeutics to your portfolios can decrease your overall portfolio volatility.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Equity Valuation
Check real value of public entities based on technical and fundamental data
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets